HLA002
Jurkat HLA Panel Cell Lines
Synonym(s):
Immuno-oncology, CAR-T, Checkpoint Inhibitors, Immunotherapy, Oncology
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
41106514
Biological source:
human (T Lymphocyte (blood))
Growth mode:
suspension
biological source
human (T Lymphocyte (blood))
growth mode
suspension
shipped in
dry ice
storage temp.
−196°C
General description
The STR profile of these cell lines match that of its parental cell line - ECACC catalog number 88042803.
This product is a panel of eleven (11) genetically modified cell lines targeting MHC Class I HLA molecules in a Jurkat T lymphocyte parental cell line background. The full HLA panel consists of a Beta-2 microglobulin (β2M) knockout cell line and an additional ten (10) monoallelic HLA expression cell lines.
CompoZr® Zinc Finger Nuclease (ZFN) technology was used to generate the β2M knockout cell line, which does not express endogenous cell surface MHC Class I HLA molecules (HLA-A or HLA-B) as measured by fluorescence-activated cell sorting (FACS).
MISSION® lentivirus was used to generate the ten (10) monoallelic HLA cell lines, which express individual HLA-A or HLA-B subtypes on the cell surface via a β2M:HLA fusion protein as described in Nature Biotechnology 35, 765-772, (2017) and as demonstrated via FACS analysis.
This product is a panel of eleven (11) genetically modified cell lines targeting MHC Class I HLA molecules in a Jurkat T lymphocyte parental cell line background. The full HLA panel consists of a Beta-2 microglobulin (β2M) knockout cell line and an additional ten (10) monoallelic HLA expression cell lines.
CompoZr® Zinc Finger Nuclease (ZFN) technology was used to generate the β2M knockout cell line, which does not express endogenous cell surface MHC Class I HLA molecules (HLA-A or HLA-B) as measured by fluorescence-activated cell sorting (FACS).
MISSION® lentivirus was used to generate the ten (10) monoallelic HLA cell lines, which express individual HLA-A or HLA-B subtypes on the cell surface via a β2M:HLA fusion protein as described in Nature Biotechnology 35, 765-772, (2017) and as demonstrated via FACS analysis.
Biochem/physiol Actions
Derived from Jurkat FHCRC. An IL-2 producing cell line, derived by incubating the cells at 41°C for 48 hours followed by a limiting dilution cloning over macrophages.
Features and Benefits
Unlike wild type Jurkat cells, which express multiple HLA subtypes, the Jurkat HLA panel cell lines express individual MHC Class I HLA subtypes. These monoallelic HLA cell lines can be used to study peptide binding and presentation in the context of individual HLA subtypes. The panel can also be used to develop cell-based assays to evaluate candidate cancer immunotherapies and identify tumor-specific neoantigens.
Analysis Note
Tested for Mycoplasma, bacterial and fungal content, post-freeze viability, and short terminal repeat (STR) analysis for cell line identification.
Other Notes
HLA002A-1VL: Jurkat B2M KO Cells
HLA002B-1VL: Jurkat HLA-A*02:01 Cells
HLA002C-1VL: Jurkat HLA-A*01:01 Cells
HLA002D-1VL: Jurkat HLA-A*03:01 Cells
HLA002E-1VL: Jurkat HLA-A*11:01 Cells
HLA002F-1VL: Jurkat HLA-A*24:02 Cells
HLA002G-1VL: Jurkat HLA-B*15:10 Cells
HLA002H-1VL: Jurkat HLA-B*07:02 Cells
HLA002I-1VL: Jurkat HLA-B*08:01 Cells
HLA002J-1VL: Jurkat HLA-B*35:01 Cells
HLA002K-1VL: Jurkat HLA-B*40:01 Cells
HLA002B-1VL: Jurkat HLA-A*02:01 Cells
HLA002C-1VL: Jurkat HLA-A*01:01 Cells
HLA002D-1VL: Jurkat HLA-A*03:01 Cells
HLA002E-1VL: Jurkat HLA-A*11:01 Cells
HLA002F-1VL: Jurkat HLA-A*24:02 Cells
HLA002G-1VL: Jurkat HLA-B*15:10 Cells
HLA002H-1VL: Jurkat HLA-B*07:02 Cells
HLA002I-1VL: Jurkat HLA-B*08:01 Cells
HLA002J-1VL: Jurkat HLA-B*35:01 Cells
HLA002K-1VL: Jurkat HLA-B*40:01 Cells
Legal Information
CompoZr is a registered trademark of Merck KGaA, Darmstadt, Germany
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
This product is regulated in France when intended for scientific purposes, including import, export, and conservation activities (Articles L.1211-1, paragraph 2, and L.1243-4 of the French Public Health Code). The purchaser (i.e. end user) is required to obtain an import authorization from the France Ministry responsible for Research (as referenced in Article L.1245-5-1 II of the French Public Health Code) or a conservation authorization from the same ministry (as referenced in Article L.1243-4 of the French Public Health Code). By placing an order for this product, you confirm that you have obtained the appropriate import or conservation authorization for the product. For more information regarding the use of human biological samples for research purposes in France, please contact the relevant French authorities.
Storage Class
10 - Combustible liquids
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.